Clinical Research Alliance
History and Organization
The Clinical Research Alliance (CRA) was instituted in 1996 as a coalition of clinical centers across the United States working together on multiple clinical research studies. Members ask and address clinically relevant questions that would not otherwise be studied with a goal of improving the quality of life for adult patients with IBD.
The CRA is a standing committee of the Crohn’s & Colitis Foundation’s National Scientific Advisory Committee (the “NSAC”) and is comprised of two Chairs, the Foundation’s Director of Clinical Research and participating institutional and affiliate members.
Network members are independently owned primary centers consisting of hospitals, medical centers, research institutes or community practices, or a group of such centers which have developed an IBD related research program approved by the Clinical Alliance and administered by a Principal Investigator (a “PI”). Any center that is a member of the CRA is eligible to participate in an active network study.
To become a member, please complete a membership application on the “Get Involved” section of this website. The Chairs will review applications and approve qualified centers. For any questions, please contact Schantel Williams at firstname.lastname@example.org
The Clinical Research Alliance shall meet as often as necessary, but at least twice a year, typically at Digestive Disease Week and at the Crohn’s and Colitis Congress. In addition, the CRA shall meet on the call of the Chairs, as needed. A quorum for CRA meetings shall be defined as 50 percent of its membership. A majority of members present and voting shall decide any issues on the agenda.